COMMUNIQUÉS West-GlobeNewswire

Inventiva annonce sa participation à la « 43rd Annual J.P. Morgan Healthcare Conference »

17/12/2024 - 22:00

Daix (France), New York City (New York, Etats Unis), le 17 décembre 2024 – Inventiva (Euronext Paris and Nasdaq :IVA) (la « Société »), société biopharmaceutique spécialisée dans le développement clinique de petites [...]

Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference

17/12/2024 - 22:00

Daix (France), New York City (New York, United States), December 17, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small [...]

Corvus Pharmaceuticals to Announce Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on December 18, 2024

17/12/2024 - 22:01

Company to host conference call and webcast at 8:00 a.m. ET / 5:00 a.m. PT on Wednesday, December 18, 2024 BURLINGAME, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical- [...]

Structure Therapeutics Announces Selection of Lead Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity

17/12/2024 - 22:01

Preclinical studies with ACCG-2671 demonstrate potent target engagement, robust weight loss, favorable safety profile and PK properties supportive of once-daily dosing in humans ACCG-2671 is the most advanced oral small [...]

Inotiv, Inc. Launches Proposed Public Offering of Common Shares

17/12/2024 - 22:03

WEST LAFAYETTE, Ind., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”) , a leading contract research organization specializing in nonclinical and analytical drug discovery and development [...]

Soleno Therapeutics Enters Into $200 Million Debt Financing with Oxford Finance LLC

17/12/2024 - 22:05

Up to $200 million financing, includes $50 million upfront REDWOOD CITY, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing [...]

NeuroMetrix to be Acquired by electroCore

17/12/2024 - 22:05

NeuroMetrix shareholders to receive cash and Contingent Value Rights WOBURN, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (“NeuroMetrix” or the “Company”) (Nasdaq: NURO) today announced it has entered into [...]

Regeneron Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

17/12/2024 - 22:05

TARRYTOWN, N.Y., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) will webcast its presentation at the 43 rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025. The [...]

electroCore to Acquire NeuroMetrix, Gaining Access to its Quell Platform and Positioning Itself as a Significant Player in Non-Invasive Bioelectronic Medicine and Wellness

17/12/2024 - 22:05

The Quell® platform will strengthen our position as a significant player in the bioelectronic health and wellness sector Company to discuss acquisition and host investor Q&A in a webcast today at 4:30 p.m. EST [...]

Clover Health to Participate in Upcoming 43rd Annual J.P. Morgan Healthcare Conference

17/12/2024 - 22:05

JERSEY CITY, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Remote-First Company -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Executive Officer [...]

BriaPro Therapeutics Corp. Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures

17/12/2024 - 22:05

VANCOUVER, British Columbia, Dec. 17, 2024 (GLOBE NEWSWIRE) -- BriaPro Therapeutics Corp. (“ BriaPro ” or the “ Company ”), a pre-clinical stage immunotherapy company developing binding agents and proteins with the [...]

BriaCell Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures

17/12/2024 - 22:05

PHILADELPHIA and VANCOUVER, British Columbia, Dec. 17, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that [...]

CooperCompanies to Present at the J.P. Morgan Healthcare Conference

17/12/2024 - 22:15

SAN RAMON, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, today announced it will participate at the J.P. Morgan Healthcare Conference on Tuesday, January 14, [...]

NANOBIOTIX présentera sa vision pour révolutionner la conception et le développement de médicaments à travers sa prochaine plateforme nanothérapeutique le 19 décembre 2024

17/12/2024 - 22:15

Les participants peuvent s’inscrire ici pour assister à l’événement virtuel diffusé à 15h00 CET / 9h00 ET. PARIS et CAMBRIDGE, Mass., 17 déc. 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : NBTX – la « [...]

NANOBIOTIX to Introduce Vision for Transforming Drug Design and Development with Next Nanotherapeutic Platform on 19 December 2024

17/12/2024 - 22:15

Participants can register here for the virtual event airing 9:00am ET / 3:00pm CET PARIS and CAMBRIDGE, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘ Company ’’), a late- [...]

Bio Usawa Names Former Ghana Food and Drug Authority Director Eric Karikari-Boateng as Head of Global Regulatory Strategy

17/12/2024 - 16:15

SAN FRANCISCO and KIGALI, Rwanda, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Bio Usawa, Inc., a leading biotechnology company committed to delivering affordable and accessible monoclonal antibody-based therapies for cancer, [...]

WAKE RADIOLOGY ADDS NEW PHYSICIAN TO EXPANDING PRACTICE

17/12/2024 - 16:15

Raleigh, N.C., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Wake Radiology UNC Health Rex, the leading provider of outpatient medical imaging in the Triangle, has welcomed Yasser J. El-Abd, M.D., Interventional Radiologist, to its [...]

Kno2 and Pennant Announce Strategic Partnership to Revolutionize Patient Care through QHIN services

17/12/2024 - 17:05

BOISE, Idaho, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Kno2, the company leading the future of healthcare communication, announced today a partnership with The Pennant Group, Inc (NASDAQ: PNTG) to drive automation and [...]

Merus annonce le traitement du premier patient dans le cadre d’un essai de phase 2 portant sur le pétosemtamab dans le CCRm en 3e ligne et lignes ultérieures

17/12/2024 - 17:50

UTRECHT, Pays-Bas et CAMBRIDGE, Massachusetts, 17 déc. 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), une société spécialisée dans l’oncologie au stade clinique développant des anticorps de pleine longueur [...]